Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Hematology/Oncology ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- A brief history of palliative radiation oncology.in: Lutz S. Chow E. Hoskin P. Radiation oncology in palliative cancer care. Wiley-Blackwell, First. West Sussex2013: 3-14
- Role of radiation therapy in palliative care of the patient with cancer.J Clin Oncol. 2014; 32: 2913-2919
- Palliative radiation therapy for bone metastases: update of an ASTRO evidence-based guideline.Pract Radiat Oncol. 2017; 7: 4-12
- Brain metastases: what’s new with an old problem?.Curr Opin Support Palliat Care. 2012; 6: 85-90
- Palliative thoracic radiation therapy for non-small cell lung cancer: 2018 update of an American Society for Radiation Oncology (ASTRO) evidence-based guideline.Pract Radiat Oncol. 2018; 8: 245-250
- Bleeding in cancer patients and its treatment: a review.Ann Palliat Med. 2018; 7: 265-273
- An innovative rapid response radiotherapy program to reduce waiting time for palliative radiotherapy.Support Care Cancer. 2006; 14: 38-43
- Symptom clusters in patients with advanced cancer: sub-analysis of patients reporting exclusively non-zero ESAS scores.Palliat Med. 2012; 26: 826-833
- Palliative radiation oncology programs: design, build, succeed!.Ann Palliat Med. 2019; 8: 264-273
- The supportive and palliative radiation oncology service: a dedicated model for palliative radiation oncology care.J Adv Pract Oncol. 2015; 6 (Available at:) (Accessed August 28, 2019): 135-140
- CARE track for advanced cancer: impact and timing of an outpatient palliative care clinic.J Palliat Med. 2016; 19: 57-63
- STAT RT: a prospective pilot clinical trial of Scan-Plan-QA-Treat stereotactic body radiation therapy for painful osseous metastases.Ann Palliat Med. 2019; 8: 1207
- Advanced radiotherapy for metastatic disease—a major stride or a futile effort?.Ann Palliat Med. 2019; 8: 337-351
- Palliative radiotherapy--new approaches.Semin Oncol. 2011; 38: 443-449
- Palliative radiotherapy for advanced malignancies in a changing oncologic landscape: guiding principles and practice implementation.Ann Palliat Med. 2014; 3 (Available at:) (Accessed September 22, 2014): 192-202
- Palliative radiotherapy.BMJ. 2018; 360: k821
- Palliative radiotherapy: current status and future directions.Semin Oncol. 2014; https://doi.org/10.1053/j.seminoncol.2014.09.021
- Beyond palliative radiotherapy: a pilot multidisciplinary brain metastases clinic.Support Care Cancer. 2012; 20: 773-781
- Managing brain metastases patients with and without radiotherapy: initial lessons from a team-based consult service through a multidisciplinary integrated palliative oncology clinic.Support Care Cancer. 2013; 21: 3379-3386
- Radiotherapeutic and surgical management for newly diagnosed brain metastasis(es): an American Society for Radiation Oncology evidence-based guideline.Pract Radiat Oncol. 2012; 2: 210-225
- Survival, local control, and health-related quality of life in patients with oligometastatic and polymetastatic spinal tumors: a multicenter, international study.Cancer. 2019; 125: 770-778
- The NOMS framework: approach to the treatment of spinal metastatic tumors.Oncologist. 2013; 18: 744-751
- Solitary colorectal liver metastasis: resection determines outcome.Arch Surg. 2006; 141: 460-467
- The role of radiofrequency ablation for treatment of metachronous isolated hepatic metastasis from colorectal cancer.Medicine (Baltimore). 2016; 95: e4999
- Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.Lancet Oncol. 2016; 17: 1672-1682
- Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.Lancet. 2019; 393: 2051-2058
- Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, phase II, randomized study.J Clin Oncol. 2019; 37: 1558-1565
- Defining the radiation oncologist’s role in palliative care and radiotherapy.Ann Palliat Med. 2019; 8: 246-263
- Single-fraction stereotactic vs conventional multifraction radiotherapy for pain relief in patients with predominantly nonspine bone metastases.JAMA Oncol. 2019; 5: 872
- A palliative radiation oncology consult service’s impact on care of advanced cancer patients.J Palliat Med. 2018; 21: 438-444
- Building a palliative radiation oncology program: from bedside to B.E.D.Pract Radiat Oncol. 2017; 7: 203-208
- PRADO: a palliative care model for every radiation oncology practice.Int J Radiat Oncol Biol Phys. 2017; 99: 518-519
- A multidisciplinary breast cancer brain metastases clinic: the University of North Carolina experience.Oncologist. 2016; 21: 16-20
- Supportive and palliative radiation oncology service: impact of a dedicated service on palliative cancer care.Pract Radiat Oncol. 2014; 4: 247-253
- Burden of palliative care issues encountered by radiation oncologists caring for patients with advanced cancer.Pract Radiat Oncol. 2017; 7: e517-e524
- STAT-RAD: a potential real-time radiation therapy workflow.in: Natanasabapathi G. Modern practices in radiation therapy. InTech, London2012: 1-19https://doi.org/10.5772/2019
- Use of single- versus multiple-fraction palliative radiation therapy for bone metastases: population-based analysis of 16,898 courses in a Canadian Province.Int J Radiat Oncol Biol Phys. 2014; 89: 1092-1099
- Impact of using audit data to improve the evidence-based use of single-fraction radiation therapy for bone metastases in British Columbia.Int J Radiat Oncol Biol Phys. 2016; 94: 40-47
- A review of the rapid response radiotherapy program in patients with advanced cancer referred for palliative radiotherapy over two decades.Support Care Cancer. 2019; 27: 2131-2134
- Rapid access palliative radiation therapy programs: an efficient model of care.Future Oncol. 2015; 11: 2417-2426
- Prospective analysis of patient reported symptoms and quality of life in patients with incurable lung cancer treated in a rapid access clinic.Lung Cancer. 2017; 112: 35-40
- Development of the rapid access radiotherapy clinic at the University of Pennsylvania.Society of Radiation Oncology Administrators, Chicago2019
- Attitudes of radiation oncologists toward palliative and supportive care in the United States: report on national membership survey by the American Society for Radiation Oncology (ASTRO).Pract Radiat Oncol. 2017; 7: 113-119
- Radiation oncology resident palliative education.Pract Radiat Oncol. 2017; 7: e439-e448
- Palliative care and palliative radiation therapy education in radiation oncology: a survey of US radiation oncology program directors.Pract Radiat Oncol. 2017; 7: 234-240
- Patient-clinician communication: American Society of Clinical Oncology Consensus guideline.J Clin Oncol. 2017; 35: 3618-3632
- Prognostic models predicting survival of patients with brain metastases: integration of lactate dehydrogenase, albumin and extracranial organ involvement.Clin Oncol (R Coll Radiol). 2014; 26: 447-452
- Palliative radiotherapy tailored to life expectancy in end-stage cancer patients: reality or myth?.Cancer. 2010; 116: 3251-3256
- Effect of the serious illness care program in outpatient oncology.JAMA Intern Med. 2019; 179: 751
- Values and options in cancer care (VOICE): study design and rationale for a patient-centered communication and decision-making intervention for physicians, patients with advanced cancer, and their caregivers.BMC Cancer. 2013; 13: 188
- The cultivation of prognostic awareness through the provision of early palliative care in the ambulatory setting: a communication guide.J Palliat Med. 2013; 16: 894-900
- Predictive model for survival in patients with advanced cancer.J Clin Oncol. 2008; 26: 5863-5869
- External validation of the number of risk factors score in a palliative care outpatient clinic at a comprehensive cancer center.J Palliat Med. 2014; 17: 797-802
- The TEACHH model to predict life expectancy in patients presenting for palliative spine radiotherapy: external validation and comparison with alternate models.Support Care Cancer. 2018; 26: 2217-2227
- Predicting life expectancy in patients with metastatic cancer receiving palliative radiotherapy: the TEACHH model.Cancer. 2014; 120: 134-141
- The NEAT predictive model for survival in patients with advanced cancer.Cancer Res Treat. 2018; 50: 1433-1443
- Increased risk of ischemic bowel complications during treatment with bevacizumab after pelvic irradiation: report of three cases.Int J Radiat Oncol Biol Phys. 2006; 64: 1295-1298
- Phase I trial evaluating the safety of bevacizumab with concurrent radiotherapy and capecitabine in locally advanced pancreatic cancer.J Clin Oncol. 2006; 24: 1145-1151
- Tracheoesophageal fistula formation in patients with lung cancer treated with chemoradiation and bevacizumab.J Clin Oncol. 2010; 28: 43-48
- Phase I dose escalation study of concurrent palliative radiation therapy with sorafenib in three anatomical cohorts (Thorax, Abdomen, Pelvis): the TAP study.Radiother Oncol. 2017; 124: 74-79
- Bowel perforation after radiotherapy in a patient receiving sorafenib.J Clin Oncol. 2008; 26: 2405-2406
- Gastrointestinal toxicities with combined antiangiogenic and stereotactic body radiation therapy.Int J Radiat Oncol Biol Phys. 2015; 92: 568-576
- Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.N Engl J Med. 2014; 370: 709-722
- AVAglio: phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme.Adv Ther. 2011; 28: 334-340
- Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer.J Clin Oncol. 2014; 32: 3824-3830
- A phase II trial of erlotinib and concurrent palliative thoracic radiation for patients with non-small-cell lung cancer.Clin Lung Cancer. 2016; 17: 142-149
- Safety of cranial radiotherapy concurrent with tyrosine kinase inhibitors in non-small cell lung cancer patients: a systematic review.Cancer Treat Rev. 2015; 41: 634-645
- Infusional 5-fluorouracil and ZD1839 (Gefitinib-Iressa) in combination with preoperative radiotherapy in patients with locally advanced rectal cancer: a phase I and II Trial (1839IL/0092).Int J Radiat Oncol Biol Phys. 2008; 72: 644-649
- Stereotactic radiation therapy can safely and durably control sites of extra-central nervous system oligoprogressive disease in anaplastic lymphoma kinase-positive lung cancer patients receiving crizotinib.Int J Radiat Oncol Biol Phys. 2014; 88: 892-898
- Optimal timing and clinical value of radiotherapy in advanced ALK-rearranged non-small cell lung cancer with or without baseline brain metastases: implications from pattern of failure analyses.Radiat Oncol. 2019; 14: 44
- Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG phase III trial N9831.J Clin Oncol. 2009; 27: 2638-2644
- Concurrent trastuzumab with adjuvant radiotherapy in HER2-positive breast cancer patients: acute toxicity analyses from the French multicentric study.Ann Oncol. 2008; 19: 1110-1116
- Combination of radiotherapy and double blockade HER2 with pertuzumab and trastuzumab for HER2-positive metastatic or locally recurrent unresectable and/or metastatic breast cancer: assessment of early toxicity.Cancer Radiother. 2017; 21: 114-118
- Avoiding severe toxicity from combined BRAF inhibitor and radiation treatment: consensus guidelines from the Eastern Cooperative Oncology Group (ECOG).Int J Radiat Oncol Biol Phys. 2016; 95: 632-646
- Unusual acute and delayed skin reactions during and after whole-brain radiotherapy in combination with the BRAF inhibitor vemurafenib. Two case reports.Strahlenther Onkol. 2014; 190: 229-232
- Safety and efficacy of palbociclib and radiation therapy in patients with metastatic breast cancer: initial results of a novel combination.Adv Radiat Oncol. 2019; 4: 453-457
- Radiation therapy and PD-1/PD-L1 blockade: the clinical development of an evolving anticancer combination.J Immunother Cancer. 2018; 6: 46
- Impact of radiotherapy administered simultaneously with systemic treatment in patients with melanoma brain metastases within MelBase, a French multicentric prospective cohort.Eur J Cancer. 2019; 112: 38-46
- Radiation and PD-1 inhibition: favorable outcomes after brain-directed radiation.Radiother Oncol. 2017; 124: 98-103
- Multicenter evaluation of the tolerability of combined treatment with PD-1 and CTLA-4 immune checkpoint inhibitors and palliative radiation therapy.Int J Radiat Oncol Biol Phys. 2017; 98: 344-351
- Indications, barriers and paths to advancement in palliative radiation oncology.Applied Radiation Oncology. 2018; 7 (Available at:) (Accessed August 1, 2018): 18-25
- Pneumonitis resulting from radiation and immune checkpoint blockade illustrates characteristic clinical, radiologic and circulating biomarker features.J Immunother Cancer. 2019; 7: 112
- Palliative radiation therapy in the last 30 days of life: a systematic review.Radiother Oncol. 2017; 125: 193-199
- Palliative radiotherapy at the end of life: a critical review.CA Cancer J Clin. 2014; 64: 295-310
- Palliative radiotherapy near the end of life.BMC Palliat Care. 2019; 18: 29
- Use of palliative chemo- and radiotherapy at the end of life in patients with cancer: a retrospective cohort study.Am J Hosp Palliat Care. 2017; 34: 801-805
- Development and validation of a model predicting short survival (death within 30 days) after palliative radiotherapy.Anticancer Res. 2014; 34 (Available at:) (Accessed September 21, 2014): 877-885
- Patterns of care among patients receiving radiation therapy for bone metastases at a large academic institution.Int J Radiat Oncol Biol Phys. 2014; 89: 1100-1105
- Characterization of patients receiving palliative chemo- and radiotherapy during end of life at a regional cancer center in Norway.Acta Oncol. 2014; : 1-8https://doi.org/10.3109/0284186X.2014.948061
- Use of radiation therapy in the last 30 days of life among a large population-based cohort of elderly patients in the United States.J Clin Oncol. 2013; 31: 80-87
Article info
Publication history
Published online: October 28, 2019
Identification
Copyright
© 2019 Elsevier Inc. All rights reserved.
